Insulet (Nasdaq:PODD) announced today that it began a full U.S. launch of Omnipod 5 with the Dexcom G7 continuous glucose monitor (CGM). The company also announced a series of launches and updates, including a limited release of the Omnipod 5 App for iPhone. Insulet also made Omnipod 5 available in France and launched the system […]
Dexcom
Dexcom launches G7 with Apple Watch integration in the U.S.
Dexcom (Nasdaq:DXCM) announced today that its G7 continuous glucose monitor (CGM) now connects directly to the Apple Watch in the U.S. San Diego-based Dexcom first announced the addition of this capability in March. The official launch makes G7 the first and only CGM available with a direct-to-Apple-Watch feature. It offers users the freedom and convenience […]
Dexcom earns CGM reimbursement in France for type 2 diabetes
Dexcom (Nasdaq:DXCM) announced today that its Dexcom ONE sensor received reimbursement for those with type 2 diabetes in France. The previous-generation Dexcom ONE sensor originally launched in France last fall. At that time, it covered patients two years and older with type 1 and type 2 diabetes undergoing intensive insulin therapy. Now, the company can […]
Dexcom, Abbott ask for another trial in CGM patent spat
Abbott (NYSE:ABT) and Dexcom (Nasdaq:DXCM) both submitted legal briefs angling for another trial in an ongoing continuous glucose monitor (CGM) patent spat. In March, the U.S. District Court for the District of Delaware found that Dexcom violated a single patent belonging to Abbott and its FreeStyle Libre sensors. However, the court found that Dexcom did […]
Tandem pairs Mobi automated insulin pump with Dexcom G7
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it integrated its Mobi insulin pump with the Dexcom G7 continuous glucose monitor (CGM). Already compatible with the previous-generation G6, Mobi now pairs with Dexcom’s latest-generation CGM. San Diego-based Tandem launched Mobi, the world’s smallest, durable automated insulin delivery (AID) system in the U.S. this year. It received […]
Dexcom launches new sensor in the UK
Dexcom (Nasdaq:DXCM) announced today that it launched the Dexcom ONE+ continuous glucose monitor (CGM) in the UK. ONE+ uses Dexcom’s established sensor design, with the company incorporating feedback from users and healthcare professionals to build it. The company said this ensured an easy-to-use, highly effective CGM experience for people treating type 1 or type 2 […]
Dexcom stock slides despite Q1 beats, sales guidance increase
Dexcom (Nasdaq:DXCM) shares took a hit after hours today on first-quarter results that came in ahead of the consensus forecast on Wall Street. Shares of DXCM dipped about 7% to $128.40 apiece after the market closed today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — closed the […]
Study highlights benefits of automated insulin delivery for children in UK
A study in the UK demonstrated significant improvements in HbA1c for users of automated insulin delivery technologies. This comes on the heels of a UK NHS initiative to provide tens of thousands of children and adults with type 1 diabetes in the country with an artificial pancreas. The study aimed to assess the efficacy of […]
Non-insulin, basal CGM use exceeds analysts’ expectations, Dexcom and Abbott to benefit
William Blair analyst Margaret Kaczor reported surprise at the increase in users of CGM within the non-insulin and basal insulin populations. Kaczor expects Dexcom and Abbott to benefit from the trend with their next-generation CGM offerings after meetings with both companies’ management. Both companies launched next-gen CGMs in recent years (Dexcom G7 and Abbott FreeStyle […]
Dexcom, MD Revolution partner to integrate CGM into remote care platform
MD Revolution today announced a partnership with Dexcom (Nasdaq:DXCM) to integrate CGM into its remote care management platform. Dexcom develops continuous glucose monitoring technology (CGM), including its latest-generation G7. The system pairs with smartphones — and now Apple Watches — to monitor the glucose levels of people with diabetes. MD Revolution’s remote care management platform […]
